Charles River Laboratories | CRL - 销售成本



金融业
股票价格
USD
资产
USD 7.73B
现金及等价物
USD 191.83M
销售成本
USD 716.51M
流动资产
USD 1.49B
流动负债
USD 1.09B
债务
USD 2.57B
EBIT
USD 119.9M
EBITDA
USD 229.8M
员工
18.6K
EPS每股收益
USD 2.06
股本和储备
USD 2.9B
销售毛利
USD 279.32M
债务利息支出
USD 26.74M
利息收入
USD -0.3
贷款资金
USD 2.66B
市值
USD 11.42B
净收入
USD -14.84M
营业费用
USD 875.93M
营业利润
USD 119.9M
普通股股本
USD 48.17M
PE价格收益
29.27
税前利润
USD -294.1M
销售收入
USD 995.8M
销售和管理费用
USD 159.42M
股票
USD 359.72M
贸易债权人
USD 133.95M
应收帐款人
USD 700.25M


销售成本 更改 日
Agilent USD 845M 7M 2026-03
Align Technology USD 303.5M 60.47M 2026-03
Bio-Rad Laboratories USD 348M 38.4M 2025-12
Bruker USD 443.6M 84.4M 2026-03
Cardinal Health USD 58.54B 4.82B 2026-03
Charles River Laboratories USD 716.51M 5.76M 2026-03
Cigna USD 62.41B 4.1B 2026-03
Concord Medical Services Hldg CNY 204.9M 117.04M 2025-06
CVS Health USD 84.8B 7.32B 2026-03
Danaher USD 2.65B 294M 2026-06
Dentsply International USD 453M 65M 2026-03
Elevance Health USD 38.07B 75M 2025-12
Humana USD 26.54B 1.15B 2025-03
Illumina USD 370M 30M 2026-03
Incyte USD 104.5M 16.68M 2026-03
Intrexon USD 1.01M 344K 2024-06
IQVIA Holdings USD 3.08B 161M 2026-03
Laboratory Of America USD 2.6B 4.2M 2026-03
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Lonza CHF 2.28B 189M 2025-06
McKesson USD 92.25B 10.22B 2026-03
Merck EUR 2.07B 219M 2026-03
Mettler Toledo International USD 410.92M 63.05M 2026-03
Novartis USD 3.46B 83M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Quest Diagnostics USD 1.99B 57M 2026-03
Revvity USD 323.46M 26.93M 2026-03
Thermo Fisher Scientific USD 6.96B 620M 2026-03
United Therapeutics USD 133.4M 341.3M 2026-03
UnitedHealth USD 86.31B 8.41B 2026-03
Veradigm USD 124.74M 56.25M 2022-12
Waters USD 725M 350.06M 2026-03
West Pharmaceutical Services USD 548.5M 47.4M 2026-03